• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Anika Therapeutics (ANIK)

Common Shares
Sell: $11.16|Buy: $28.1|Change: 0.27 (0.98%)

This share can be held in a Dealing accountISALifetime ISAJISASIPP

Company profile

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.

Address

32 Wiggins Avenue
Bedford
MA
USA
01730

Telephone

+1 781 4579000

Website

https://www.anika.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Anika Therapeutics Inc First Quarter Earnings Conference Call for 20252025-05-08T17:30:00
Anika Therapeutics Inc First Quarter Earnings Results for 20252025-05-08T00:00:00
Anika Therapeutics Inc Annual Report for 20242025-03-14T00:00:00
Anika Therapeutics Inc Fourth Quarter Earnings Conference Call for 20242025-03-13T17:00:00
Anika Therapeutics Inc Fourth Quarter Earnings Results for 20242025-03-13T00:00:00
Anika Therapeutics Inc Third Quarter Earnings Conference Call for 20242024-11-01T17:30:00
Anika Therapeutics Inc Third Quarter Earnings Results for 20242024-11-01T00:00:00
Anika Therapeutics Inc Second Quarter Earnings Conference Call for 20242024-08-08T17:00:00
Anika Therapeutics Inc Second Quarter Earnings Results for 20242024-08-08T00:00:00
Anika Therapeutics Inc Annual General Meeting for 20242024-06-14T09:00:00
Anika Therapeutics Inc First Quarter Earnings Conference Call for 20242024-05-08T17:30:00
Anika Therapeutics Inc First Quarter Earnings Result for 20242024-05-08T00:00:00

Previous key dates

NameKey Date
Anika Therapeutics Inc First Quarter Earnings Conference Call for 20242024-05-08T17:30:00
Anika Therapeutics Inc First Quarter Earnings Result for 20242024-05-08T00:00:00
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference2024-04-08T14:15:00
Anika Therapeutics Inc Annual Report for 20232024-03-15T00:00:00
Anika Therapeutics Inc Fourth Quarter Earnings Conference Call for 20232024-03-13T17:00:00
Anika Therapeutics Inc Fourth Quarter Earnings Result for 20232024-03-13T00:00:00
Anika Therapeutics Inc Third Quarter Earnings Conference Call for 20232023-11-02T17:30:00
Anika Therapeutics Inc Third Quarter Earnings Result for 20232023-11-02T00:00:00
Anika Therapeutics Inc Second Quarter Earnings Conference Call for 20232023-08-08T17:00:00
Anika Therapeutics Inc Second Quarter Earnings Result for 20232023-08-08T00:00:00
Anika Therapeutics Inc Annual General Meeting for 20232023-06-14T09:00:00
Anika Therapeutics Inc First Quarter Earnings Conference Call for 20232023-05-09T17:00:00
Anika Therapeutics Inc First Quarter Earnings Result for 20232023-05-09T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.